Objective:To analyze the epidemiological characteristics of respiratory syncytial virus (RSV) infections in hospitalized children under five years of age with acute respiratory infections in Qingdao, China, from 2023 to 2025.Methods:This cross-sectional study enrolled children under five years hospitalized with acute respiratory infections between May 1, 2023, and June 30, 2025. Nucleic acid testing was performed for six respiratory pathogens. Participants were stratified into seven age groups: 0 to 28 days, 29 days to <6 months, 6 to <12 months, 1 to <2 years, 2 to <3 years, 3 to <4 years, and 4 to <5 years. Intergroup differences were analyzed using Chi-square tests, with Bonferroni correction (adjusted α=0.016 7) for peak rate comparisons across three epidemic seasons. Results:Among 16 613 children, RSV was detected in 3 280 cases (19.74%), representing the highest pathogen detection rate. Infants under one year accounted for 56.37% (1 849/3 280) of RSV-positive cases, with significantly higher positivity rates in the 0-28 days [25.22% (286/1 134)], 29 days to <6 months [26.66% (1 072/4 021)], and 6 to <12 months [24.92% (491/1 970)] groups compared to other age groups ( χ2=314.20, P<0.001). Co-infections occurred in 13.66% (448/3 280) of RSV-positive cases, primarily with rhinovirus (6.13%, 201/ 3 280), followed by adenovirus and Mycoplasma pneumoniae (3.35% each, 110/3 280). Epidemiological surveillance revealed an off-season outbreak from May to July 2023 (duration ≥14 weeks, peak positivity rate 71.15%), while both 2024 (20 weeks, peak 52.55%) and 2025 (24 weeks, peak 46.49%) exhibited typical winter-spring seasonal patterns. The 2023 peak rate significantly exceeded those of subsequent years (all pairwise P<0.016 7). Conclusion:RSV is the predominant pathogen among hospitalized children under five years with acute respiratory infections in Qingdao, with infants under one year representing the highest-risk population. The epidemiological pattern demonstrates a transition from post-pandemic off-season outbreaks to prolonged winter-spring epidemics, highlighting the need for continued surveillance and targeted prevention strategies.

Objective To evaluate the predictive value of patent ductus arteriosus(PDA)for the incidence and mortality of neonatal pulmonary hemorrhage(NPH)in infants with a gestational age(GA)of≤32 weeks.Methods Retrospective analysis of clinical data from premature infants with GA≤32 weeks consecutively admitted between January 2021 and June 2024.The analyzed clinical characteristics included GA,birth weight(WT),mode of delivery,diseases experienced by the infants,and maternal perinatal factors.Infants were categorized based on the presence or absence of NPH,and the clinical features of both groups were compared.Furthermore,infants with NPH and hemodynamically significant patent ductus arteriosus(hsPDA)were subdivided according to in-hospital mortality for additional analysis.Results The study included a total of 511 pediatric patients,of whom 92 cases were diagnosed with NPH.NPH was strongly correlated with mechanical ventilation(MV),high-frequency oscil-lation(HFO),hsPDA,disseminated intravascular coagulation(DIC),and intraventricular hemorrhage(IVH)(r=0.443,0.407,0.352,0.325,0.310,respectively;all P<0.001).Neonatal respiratory distress syndrome(NRDS)(grades 3-4),IVH,MV,HFO,DIC,and hsPDA were identified as independent risk factors for NPH in infants≤32 weeks of GA(OR=2.641,2.097,1.065,2.298,5.550,3.820,respectively;all P<0.05).GA,WT,PDA diameter,PDA velocity,left ventricular output(LVO),velocity of the late diastolic a'wave in the left ventricle(LV a'),and neonatal asphyxia(NA)were significant factors influencing NPH combined with hsPDA(all P<0.05).The PDA severity score(PDAsc)was determined to be a risk factor for mortality in infants≤32 weeks of GA with NPH and hsPDA(OR=1.265,95%CI 1.031-1.553,P=0.024).A strong correlation was observed between the predicted probability of death in infants with NPH and PDA and PDAsc(r=0.901,P=0.001).The ROC curve analysis demonstrated that PDAsc served as an ideal predictor of mortality in infants with NPH and PDA(AUC=0.687,P=0.002).Conclusions hsPDA is an independent risk factor for the development of NPH in infants≤32 weeks of GA.Additionally,PDAsc serves as a significant risk factor for mortality in infants≤32 weeks of GA who have both NPH and PDA,indicating a strong correlation and potential predictive value.

Objective To evaluate the predictive value of patent ductus arteriosus(PDA)for the incidence and mortality of neonatal pulmonary hemorrhage(NPH)in infants with a gestational age(GA)of≤32 weeks.Methods Retrospective analysis of clinical data from premature infants with GA≤32 weeks consecutively admitted between January 2021 and June 2024.The analyzed clinical characteristics included GA,birth weight(WT),mode of delivery,diseases experienced by the infants,and maternal perinatal factors.Infants were categorized based on the presence or absence of NPH,and the clinical features of both groups were compared.Furthermore,infants with NPH and hemodynamically significant patent ductus arteriosus(hsPDA)were subdivided according to in-hospital mortality for additional analysis.Results The study included a total of 511 pediatric patients,of whom 92 cases were diagnosed with NPH.NPH was strongly correlated with mechanical ventilation(MV),high-frequency oscil-lation(HFO),hsPDA,disseminated intravascular coagulation(DIC),and intraventricular hemorrhage(IVH)(r=0.443,0.407,0.352,0.325,0.310,respectively;all P<0.001).Neonatal respiratory distress syndrome(NRDS)(grades 3-4),IVH,MV,HFO,DIC,and hsPDA were identified as independent risk factors for NPH in infants≤32 weeks of GA(OR=2.641,2.097,1.065,2.298,5.550,3.820,respectively;all P<0.05).GA,WT,PDA diameter,PDA velocity,left ventricular output(LVO),velocity of the late diastolic a'wave in the left ventricle(LV a'),and neonatal asphyxia(NA)were significant factors influencing NPH combined with hsPDA(all P<0.05).The PDA severity score(PDAsc)was determined to be a risk factor for mortality in infants≤32 weeks of GA with NPH and hsPDA(OR=1.265,95%CI 1.031-1.553,P=0.024).A strong correlation was observed between the predicted probability of death in infants with NPH and PDA and PDAsc(r=0.901,P=0.001).The ROC curve analysis demonstrated that PDAsc served as an ideal predictor of mortality in infants with NPH and PDA(AUC=0.687,P=0.002).Conclusions hsPDA is an independent risk factor for the development of NPH in infants≤32 weeks of GA.Additionally,PDAsc serves as a significant risk factor for mortality in infants≤32 weeks of GA who have both NPH and PDA,indicating a strong correlation and potential predictive value.

Objective:To analyze the epidemiological characteristics of respiratory syncytial virus (RSV) infections in hospitalized children under five years of age with acute respiratory infections in Qingdao, China, from 2023 to 2025.Methods:This cross-sectional study enrolled children under five years hospitalized with acute respiratory infections between May 1, 2023, and June 30, 2025. Nucleic acid testing was performed for six respiratory pathogens. Participants were stratified into seven age groups: 0 to 28 days, 29 days to <6 months, 6 to <12 months, 1 to <2 years, 2 to <3 years, 3 to <4 years, and 4 to <5 years. Intergroup differences were analyzed using Chi-square tests, with Bonferroni correction (adjusted α=0.016 7) for peak rate comparisons across three epidemic seasons. Results:Among 16 613 children, RSV was detected in 3 280 cases (19.74%), representing the highest pathogen detection rate. Infants under one year accounted for 56.37% (1 849/3 280) of RSV-positive cases, with significantly higher positivity rates in the 0-28 days [25.22% (286/1 134)], 29 days to <6 months [26.66% (1 072/4 021)], and 6 to <12 months [24.92% (491/1 970)] groups compared to other age groups ( χ2=314.20, P<0.001). Co-infections occurred in 13.66% (448/3 280) of RSV-positive cases, primarily with rhinovirus (6.13%, 201/ 3 280), followed by adenovirus and Mycoplasma pneumoniae (3.35% each, 110/3 280). Epidemiological surveillance revealed an off-season outbreak from May to July 2023 (duration ≥14 weeks, peak positivity rate 71.15%), while both 2024 (20 weeks, peak 52.55%) and 2025 (24 weeks, peak 46.49%) exhibited typical winter-spring seasonal patterns. The 2023 peak rate significantly exceeded those of subsequent years (all pairwise P<0.016 7). Conclusion:RSV is the predominant pathogen among hospitalized children under five years with acute respiratory infections in Qingdao, with infants under one year representing the highest-risk population. The epidemiological pattern demonstrates a transition from post-pandemic off-season outbreaks to prolonged winter-spring epidemics, highlighting the need for continued surveillance and targeted prevention strategies.

Perimenopausal syndrome （MPS）， a common endocrine system disease， is one of the diseases responding specifically to traditional Chinese medicine （TCM）. The China Association of Chinese Medicine organized experts in endocrinology， gynecology， and interdisciplinary fields of both Western and Chinese medicine to discuss the advantages and challenges of diagnosing and treating MPS with Western medicine， TCM， and integrative medicine. Experts at the conference believe that MPS is initiated by estrogen decline and rooted in deficiency， with the pathogenesis being imbalance between Yin and Yang in the kidney. The hormone replacement therapy in Western medicine for menopause can rapidly alleviate related symptoms by quickly restoring the estrogen level and timely detect and delay complications of menopause， whereas such a therapy has certain risks， necessitating close monitoring of adverse reactions. Moreover， the various contraindications and precautions limit the clinical application of the hormone replacement therapy. TCM has advantages in synergistically alleviating symptoms such as hot flashes， sweating， sleep disorders， and emotional abnormalities of MPS without causing obvious adverse reactions. However， its efficacy is slower than the hormone replacement therapy， and the TCM evidence for preventing and treating complications of menopause remains unclear. Three suggestions were proposed for the future development of both Western and TCM for ameliorating MPS. First， an integrated diagnosis and treatment system for MPS with both Western and Chinese medicine should be established. Second， high-quality evidence-based interventions for MPS should be developed with TCM alone or in combination with Western medicine. Third， efforts should be made to promote the new TCM drug development and the interdisciplinary cooperation for treating MPS.

Objective To explore the effect of histologic chorioamnionitis(HCA)on clinical outcomes of preterm infants with a gestational age<34 weeks.Methods This retrospective study enrolled 497 cases of premature infants with a gestational age<34 weeks and their mothers who were hospitalized in the Qingdao Women and Children's Hospital from January 2019 to December 2022.According to whether the pathology of placenta was diagnosed as HCA or not,patients were divided into the HCA group(257 cases)and the control group(240 cases).The propensity score matching analysis was performed at a ratio of 1︰1.Ten items were matched,including gestational age,birth weight,gender,cesarean section,gestational diabetes mellitus,gestational hypertension,placental abruption,premature rupture of membranes,use of antenatal glucocorticoids and assisted reproductive technology.The differences of major complications and survival rate were compared between the two groups.Results A total of 156 pairs premature infants were successfully matched.Before matching,the incidences of early-onset sepsis(EOS)and bronchopulmonary dysplasia(BPD)were higher in the HCA group than those of the control group(26.1%vs.7.5%,45.1%vs.25.8%,P＜0.01).The incidence of EOS was higher in the HCA group than that of the control group after matching(24.4%vs.7.7%,P＜0.01),and the incidence of neonatal respiratory distress syndrome(NRDS)was significantly lower in the HCA group than that in the control group after matching(34.0%vs.46.8%,P＜0.05).There were no significant differences in survival rate and the incidences of other complications between the two groups before and after matching(P>0.05).Conclusion Preterm infants exposed to HCA have a higher risk of EOS and a lower risk of NRDS after propensity score matching.HCA has no significant effect on survival rate and other complications of premature infants.

Objective:To investigate the perinatal risk factors and correlation between bronchopulmonary dysplasia (BPD) and retinopathy of prematurity (ROP).Methods:A retrospective analysis was performed on 173 preterm infants born at less than 32 weeks' gestation with BPD who were admitted to the neonatal intensive care unit (NICU) of the Women and Children's Hospital of Qingdao University from June 2017 to July 2022. According to the diagnostic criteria for ROP, these preterm infants were divided into the ROP group ( n=64) and the non-ROP group ( n=109). Chi-square test, two independent samples t-test, and Mann-Whitney U test were used to compare the general data, treatment, and the incidence of complications between the two groups. Multivariate logistic stepwise regression analysis was used to analyze the independent risk factors of ROP in preterm infants with BPD and the receiver operating characteristic (ROC) curve was drawn to analyze the predictive value of independent risk factors on ROP. The correlation between the severity of BPD and the incidence of ROP was analyzed. Results:The gestational age at birth [(28.0±1.1) vs. (28.8±1.2) weeks, t=4.01], the birth weight [(1 075.9±141.4) vs. (1 143.2±168.6) g, t=2.68], the partial pressure of carbon dioxide [42.5 mmHg (1 mmHg=0.133 kPa) (34.0-51.0 mmHg) vs. 47.0 mmHg (39.0-54.0 mmHg), Z=－2.31], and the total fluid intake on the first day of birth [80.0 ml (72.3-88.7 ml) vs. 83.6 ml (76.6-92.8 ml), Z=－2.28] in the ROP group were all lower than those in the non-ROP group (all P<0.05). While the prothrombin time [15.7 s (14.1-17.7 s) vs. 14.6 s (13.1-16.7 s), Z=－2.17], activated partial thromboplastin time [64.7 s (52.9-77.9 s) vs. 55.8 s (48.4-68.9 s), Z=－2.12], the proportion of patients treated with pulmonary surfactant [71.9% (46/64) vs. 49.5% (54/109), χ 2=8.25], the total duration of oxygen supplementation [50.5 d (40.0-64.0 d) vs. 45.0 d (37.0-52.0 d), Z=－2.77], the duration of invasive ventilation [5.0 d (1.0-11.0 d) vs. 1.0 d (0.0-5.0 d), Z=－4.03], the duration of noninvasive ventilation or high-flow oxygen therapy [(31.7±12.7) vs. (26.4±13.1) d, t=－2.59], and the incidence of neonatal respiratory distress syndrome [76.6% (49/64) vs. 57.8% (63/109), χ 2=6.22] were increased in the ROP group (all P<0.05). There was no significant difference in the proportion of BPD treated with corticosteroids between the ROP and non-ROP groups [60.3% (38/63) vs. 74.3% (81/109), χ 2=3.67, P=0.055]. Multivariate logistic stepwise regression analysis showed that smaller gestational age ( OR=1.599, 95% CI: 1.126-2.272, P=0.009), less fluid intake on the first day ( OR=1.033, 95% CI: 1.004-1.062, P=0.024), and longer duration of invasive ventilation ( OR=1.076, 95% CI:1.017-1.138, P=0.011) were independent risk factors for ROP in BPD infants, while glucocorticoid treatment was an independent protective factor ( OR=0.378, 95% CI:0.173-0.827, P=0.015). Most patients with mild or moderate BPD did not develop ROP [64.6% (73/113) and 66.7% (34/51)], while those with severe BPD were more likely to be complicated by ROP (7/9) ( χ 2=6.84, P=0.033). Conclusions:BPD infants with smaller gestational age, longer duration of invasive ventilation, and less fluid intake on the first day of birth are more likely to develop ROP, while glucocorticoid therapy can reduce the incidence of ROP in this population. Severe BPD may increase the risk of ROP in infants.

Objective To analyze the evaluation value of the standard deviation of erythrocyte volume distribution width(RDW-SD),erythrocyte volume distribution width standard deviation and platelet ratio(RPR)and erythrocyte volume distribution width standard deviation and lymphocyte ratio(RLR)in the de-compensation stage of cirrhosis in primary biliary cholangitis(PBC).Methods The blood routine indexes of 68 patients with PBC admitted and treated in this hospital from January 2019 to June 2021 were retrospective-ly analyzed and divided into the compensation stage(n=36)and decompensation stage(n=32)according to the diagnostic standard.2 mL venous blood was extracted from the patient on an empty stomach in the early morning.The red blood cell(RBC),mean corpuscular volume(MCV),hemoglobin(Hb),hematocrit(HCT),mean erythrocyte hemoglobin content(MCHC),RDW-SD,white blood cell(WBC),neutrophil absolute value(N#),lymphocyte absolute value(L#),platelet count(PLT),mean platelet volume(MPV),platelet volume distribution width(PDW),etc.were detected.The platelet to lymphocyte ratio(PLR),RPR and RLR were calculated.The influencing factors of decompensation stage of PBC cirrhosis were analyzed by binary logistic regression,and the receiver operating characteristic(ROC)curve was used to analyze the diagnostic values of different indicators in the decompensation stage of PBC cirrhosis.Results There were statistically significant differences in age,RBC,Hb,HCT,RDW-SD,L #,PLT,RPR and RLR between the compensation group and decompensation group in PBC cirrhosis(P＜0.05).The binary logistic regression analysis showed that the age[odds ratios(OR)=1.087,95％confidence intervals(CI):1.015-1.165,P＜0.05],RDW-SD(OR=1.144,95％CI:1.030-1.270,P＜0.05)and RLR(OR=1.041,95％CI:1.007-1.075,P＜0.05)were the independent risk factors for progressing to the decompensation stage in the patients with PBC cirrhosis com-pensation stage.The ROC curve analysis showed that the areas under ROC curve(AUC)of RDW-SD,RPR and RLR for the diagnosis alone of decompensation stage of PBC cirrhosis were 0.726,0.778 and 0.798,re-spectively,and the differences were not statistically significant(P＞0.05).Conclusion Combined with the age factor,regular monitoring of RDW-SD,RPR and RLR levels has a high predictive value for the develop-ment of PBC cirrhosis compensation stage to decompensation stage.

Objective:To analyze the risk factors of pulmonary hemorrhage in very low and extremely low birth weight, and to provide reference for the treatment of pulmonary hemorrhage.Methods:The clinical data of very low and extremely low birth weight infants hospitalized in Qingdao Women and Children′s Hospital NICU from January 2017 to December 2021 were retrospectively analyzed.Eighty-six infants who were diagnosed with pulmonary hemorrhage were selected as the pulmonary hemorrhage group, and two hundred and two infants without pulmonary hemorrhage were selected as the control group.The differences of the survival rates, complications and parameters of platelet between the two groups were compared, and the risk factors of pulmonary hemorrhage by multivariate Logistic regression were analyzed.Results:The survival rate of pulmonary hemorrhage group and control group were 65.1%(56/86) and 90.1%(182/202), respectively.The survival rate of control group was significantly higher than that in the pulmonary hemorrhage group( χ2=26.241, P<0.01). There was no significant difference in fluid intake between the two groups within three days after birth( t=0.936, 1.811, 1.840, P=0.350, 0.073, 0.069). The multivariate Logistic regression analysis showed hemodynamically significant patent ductus arteriosus( OR=2.304, 95% CI: 0.213~1.564, P=0.010), disseminated intravascular coagulation( OR=3.143, 95% CI: 0.061~2.521, P=0.028), thrombocytopenia( OR=0.991, 95% CI: -0.015~-0.005, P=0.001) and low mean platelet volume( OR=0.337, 95% CI: -1.657~-0.739, P=0.001) were the risk factors of pulmonary hemorrhage. Conclusion:Hemodynamically significant patent ductus arteriosus, disseminated intravascular coagulation, thrombocytopenia and low mean platelet volume were associated with increased risks for pulmonary hemorrhage in very low and extremely low birth weight.These risk factors should be actively monitored and treated, which is helpful to early identify and prevent pulmonary hemorrhage.

Bisphenol A(BPA)as a typical environmental endocrine disruptor, has been widely used in daily consumer goods.It has reproductive, developmental, neurotoxicity and other biological toxicity, so it is gradually replaced by bisphenol F, bisphenol S, bisphenol AF and other analogues.Studies have shown that BPA and its analogues can enter the human body through many ways, have been detected in human blood, urine, placenta, breast milk, amniotic fluid and other tissue samples, and transmitted to the fetus, causing a variety of toxic effects, thus affecting the health of pregnant women and fetuses, and may lead to adverse pregnancy outcomes such as preterm delivery, abortion, low birth weight and so on.This article reviews the ways and current situation of exposure to BPA and its analogues during pregnancy in recent years, and its effects on maternal and fetal health, and puts forward reasonable suggestions for maternal and infant health from the point of view of exposure to adverse environmental factors, so as to provide inspiration for future research.